Background Cholinesterase inhibitors can delay the progression of Alzheimer's disease (AD). Several clinical trials of the drug in moderate to severe AD have consistently reported clinically ...
The FDA approval was tentative as this product is involved in litigation. Memantine/donepezil extended-release capsules are indicated for the treatment of moderate to severe dementia of the ...
Due to the well-known cholinergic deficit in this disease, Mori and colleagues (2012) explored the use of a cholinesterase inhibitor, donepezil, for the treatment of DLB. The authors enrolled ...
Discover all the brand names or Trade names of generic drug called Donepezil. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone looking to ...
There are four medications approved in the UK to ease a person’s dementia symptoms, including memory and thinking problems: donepezil rivastigmine galantamine memantine. These treatments are only ...